title: Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma.
abstract: The objectives of surveillance after endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma are: (i) early detection and treatment of recurrence; and (ii) early detection and treatment of metachronous esophageal squamous cell carcinoma and second primary cancers. Protocols for follow up after EMR or ESD for esophageal squamous cell carcinoma should be based on the risks of lymph node metastasis and distant metastasis as assessed on the basis of tumor staging at initial treatment. Early detection of recurrence or metachronous carcinomas often allows curative or less invasive treatment. Particular attention should be paid to the development of metachronous esophageal squamous cell carcinomas and second primary cancers (in particular, head and neck cancer and gastric cancer because of their high incidence).
authors.affiliation: Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan. ckatada@med.kitasato-u.ac.jp
authors.forename: Chikatoshi
authors.initials: C
authors.lastname: Katada
authors.forename: Manabu
authors.initials: M
authors.lastname: Muto
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tanabe
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Higuchi
authors.forename: Tohru
authors.initials: T
authors.lastname: Sasaki
authors.forename: Mizutomo
authors.initials: M
authors.lastname: Azuma
authors.forename: Kenji
authors.initials: K
authors.lastname: Ishido
authors.forename: Takashi
authors.initials: T
authors.lastname: Masaki
authors.forename: Meijin
authors.initials: M
authors.lastname: Nakayama
authors.forename: Makito
authors.initials: M
authors.lastname: Okamoto
authors.forename: Wasaburo
authors.initials: W
authors.lastname: Koizumi
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D015331:Cohort Studies; D018450:Disease Progression; D004210:Dissection; D016145:Endoscopy, Digestive System; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D004945:Esophagoscopy; D005500:Follow-Up Studies; D006801:Humans; D007564:Japan; D008207:Lymphatic Metastasis / Q000473:pathology; D009092:Mucous Membrane / Q000473:pathology / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D012307:Risk Factors